Cannabis in Dentistry: What the Evidence Really Shows

Cannabis in dentistry is increasingly discussed in clinical care, but the evidence remains early and uneven. This review maps where cannabinoids may plausibly influence pain, inflammation, and anxiety, while also highlighting where the science simply does not yet support clinical conclusions.

What This Study Teaches Us

This paper is a narrative review synthesizing pharmacologic mechanisms, preclinical findings, and limited human evidence. It identifies biologically plausible roles for cannabinoids in dental care, particularly in pain modulation, inflammatory pathways, and anxiety reduction.

However, these potential benefits are largely derived from mechanistic reasoning and extrapolation rather than controlled clinical trials in dental populations. The absence of standardized dosing, formulation clarity, and procedural guidance limits clinical applicability.

The most meaningful contribution of this paper is not proof of efficacy, but a clear framing of how early this field remains.

Why This Matters

For the Public: Patients often experience real symptom relief with cannabis, but that does not necessarily translate into proven benefit in dental care, and may come with oral health risks.

For Clinicians: Cannabis use is common but inconsistently disclosed. Understanding interactions, perioperative implications, and oral effects is increasingly necessary for safe practice.

For Research and Policy: The gap between widespread use and limited evidence underscores the need for randomized trials, dosing standards, and clinical guidelines.

What This Paper Looked At

The authors reviewed cannabinoid pharmacology, endocannabinoid system signaling, potential dental applications, oral health risks, and drug interactions. The scope spans basic science and clinical considerations without presenting new experimental data.

What the Paper Found

Cannabinoids may influence pain perception, inflammation, and anxiety through ECS modulation. These effects create a theoretical basis for use in dental contexts such as orofacial pain or procedural anxiety.

At the same time, cannabis use is associated with xerostomia, periodontal disease risk, altered wound healing, and clinically relevant drug interactions. Evidence supporting dental use remains limited and inconsistent.

How Strong Is This Evidence?

This is low-level evidence. Narrative reviews do not apply systematic methodology and cannot establish causality or quantify clinical impact. Findings should be interpreted as exploratory.

Where This Paper Deserves Skepticism

Heavy reliance on mechanistic data and animal models limits real-world applicability. Human trials specific to dentistry are scarce, and many claims are extrapolated from non-dental contexts.

Outcome measures such as pain and anxiety are heterogeneous, and comparisons with standard therapies are not rigorously tested.

What This Paper Does Not Show

This paper does not demonstrate clinical efficacy in dental patients. It does not establish dosing, timing, product selection, or long-term safety. It does not show superiority to existing treatments.

How This Fits With the Broader Clinical Conversation

This reflects a common pattern in cannabinoid research: compelling biological rationale paired with limited clinical validation. The science is ahead of the evidence required for routine care.

Dr. Caplan’s Take

The important signal here is not confirmation of benefit, but recognition of uncertainty. Cannabis may eventually have a place in dentistry, but today, the evidence does not support confident clinical use.

What a Careful Reader Should Take Away

Cannabis in dentistry is an emerging idea, not an established practice. The responsible stance is curiosity paired with restraint.

Frequently Asked Questions

Is cannabis effective for dental pain? Evidence is limited and not definitive.

Can CBD reduce dental anxiety? Possibly, but data are early.

Does cannabis harm oral health? It may increase risks like dry mouth and periodontal disease.

Are drug interactions a concern? Yes, especially via CYP450 metabolism.

Is cannabis safer than opioids? Not established in dental care.

Should dentists recommend cannabis? Only cautiously and case-by-case.

Can cannabis affect anesthesia? Chronic use may alter requirements.

Is pediatric use supported? Evidence is minimal.

What is the biggest limitation? Lack of randomized trials.

What is needed next? Controlled clinical studies.